Similar articles

• Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.

  Hauser ER, Finkelstein JE, Valle D, Brusilow SW. Hauser ER, et al. N Engl J Med. 1990 Jun 7;322(23):1641-5. doi: 10.1056/NEJM199006073222305. N Engl J Med. 1990. PMID: 2342523
• The allopurinol loading test for identification of carriers for ornithine carbamoyl transferase deficiency: studies in a healthy control population and females at risk.

  Sebesta I, Fairbanks LD, Davies PM, Simmonds HA, Leonard JV. Sebesta I, et al. Clin Chim Acta. 1994 Jan 14;224(1):45-54. doi: 10.1016/0009-8981(94)90119-8. Clin Chim Acta. 1994. PMID: 8174277
• Optimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency.

  Arranz JA, Riudor E, Rodés M, Roig M, Climent C, Rubio V, Sentís M, Burlina A. Arranz JA, et al. Clin Chem. 1999 Jul;45(7):995-1001. Clin Chem. 1999. PMID: 10388475 Clinical Trial.
• Orotic acid.

  O'Sullivan WJ. O'Sullivan WJ. Aust N Z J Med. 1973 Aug;3(4):417-22. doi: 10.1111/j.1445-5994.1973.tb03117.x. Aust N Z J Med. 1973. PMID: 4586514 Review. No abstract available.
• [Gene therapy for ornithine transcarbamylase deficiency].

  Matsuda I, Kiwaki K, Komaki S, Hoshide R, Matsuura T, Endo F. Matsuda I, et al. Tanpakushitsu Kakusan Koso. 1995 Dec;40(17):2759-64. Tanpakushitsu Kakusan Koso. 1995. PMID: 8584733 Review. Japanese. No abstract available.